News for Viking Therapeutics, Inc. (VKTX)

U.S. stocks were lower, with the Dow Jones falling over 500 points on Thursday. Shares of BJ’s Wholesale Club Holdings, Inc. BJ rose sharply during Thursday'...

We recently published an article titled These 10 Stocks Defied Tuesday's Bloodbath. In this article, we are going to take a look at where Viking Therapeutics, Inc.

Following the start of President Donald Trump’s blanket 25-percent tax on goods from Canada and Mexico on Tuesday, and a 10-percent tax on Chinese imports, both Canada and China moved to retaliate with...

Viking Therapeutics Inc (VKTX), a clinical-stage biopharmaceutical company specializing in metabolic and endocrine disorder therapies, announced on March 4, 202

PR NewswireSAN DIEGO, March 4, 2025 SAN DIEGO, March 4, 2025 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharm

Financial giants have made a conspicuous bullish move on Viking Therapeutics. Our analysis of options history for Viking Therapeutics VKTX revealed 9 unusual tr...

In the closing of the recent trading day, Viking Therapeutics, Inc. (VKTX) stood at $28.87, denoting a +0.7% change from the preceding trading day.

Exploring the robust pipeline and innovative drug candidates of Viking Therapeutics Inc.Assessing the competitive landscape and market dynamics influencing VKT

**media[552077]**

Whales with a lot of money to spend have taken a noticeably bullish stance on Viking Therapeutics. Looking at options history for Viking Therapeutics VKTX we d...

We recently published a list of 10 Oversold Biotech Stocks to Buy Now. In this article, we are going to take a look at where Viking Therapeutics, Inc.

We recently published a list of Five Chinese Firms Dominate Friday’s Top 10 Gainers. In this article, we are going to take a look at where Viking Therapeutics Inc.

We recently published a list of 10 Stocks Stand Strong Amid Cautious Market Environment. In this article, we are going to take a look at where Viking Therapeutics, Inc.

U.S. stocks were lower, with the Dow Jones falling over 200 points on Wednesday. Shares of Garmin Ltd. GRMN rose sharply during Wednesday's session after the c...

The Good Investors What We’re Reading (Week Ending 16 February 2025) What We're Reading :

Top Wall Street analysts initiated coverage on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiation...

Citi has initiated coverage of Viking (VKTX) with a neutral rating, citing the need for more data for its weight-loss drug candidate VK2735 and barriers to entry. Read more here.

Earnings Call Insights: Viking Therapeutics (NASDAQ:VKTX) Q4 2024Management ViewCEO Brian Lian highlighted 2024 as an exceptionally busy year, with...

Viking Therapeutics, Inc. (NASDAQ:VKTX) Q4 2024 Earnings Conference Call February 5, 2025 4:30 PM ETCompany ParticipantsStephanie Diaz - IR ManagerBrian...